Our new distribution partner, Universal Companies, successfully launched our brand reveel by MedSkin Solutions on the American market last week at the ISPA in Las Vegas.
Explore our new Active Resveratrol Concentrate - a powerful night concentrate to protect the skin against premature aging and to strengthen the skin’s antioxidative defense system.
Although 2021 has been challenging at times we would like to take the opportunity to celebrate the successes of our team at MedSkin Solutions Dr. Suwelack!
In our Resveratrol Study, we evaluated the effect of MedSkin’s resveratrol containing emulsion on aging related alterations to the skin. Assess the effect on skin elasticity, skin barrier function, skin smoothness, wrinkles, skin redness and skin density.
On September 1st 2021 we opened our India Liaison Office! Situated in Gurgaon near New Delhi this office opening is a tremendous milestone in our ambitions growth plans in India and is our 5th global office location at MedSkin Solutions Dr. Suwelack AG.
The SkinTERM project is a collaboration of 5 companies and 6 universities from seven different countries that will guide 12 PhD candidates in order to create a new generation of entrepreneurial, multidisciplinary and intersectorially trained scientists.
In January 2021 the FDA cleared our dermal matrix MatriDerm® for use in the management of full thickness and partial thickness wounds. MatriDerm® is our single use three-dimensional acellular dermal matrix that is comprised of our native bovine collagen and bovine elastin.